Elevance Health — Jul 15, 2026 release

As of June 30, 2026, cash and investments at the parent company totaled approximately $2.1 billion. During the second quarter of 2026, the Company repurchased 0.7 million shares of its common stock for $234 million, at a weighted average price of $344.62, and paid a quarterly dividend of $1.72 per share, representing a distribution of cash totaling $373 million. As of June 30, 2026, the Company had approximately $5.3 billion of Board approved share repurchase authorization remaining. 2 Health Benefits is comprised of Individual, Employer Group risk-based, Employer Group fee-based, BlueCard ® , Medicare, Medicaid, and Federal Employee Program businesses. Health Benefits Reportable Segment Highlights (Unaudited) (In billions) Three Months Ended June 30, 2026 June 30, 2025 Operating Revenue 1 $42.7 $41.6 Operating Gain 1 $0.9 $1.6 Operating Margin 1 2.1  % 3.8  % 1. See “Basis of Presentation” on page 5 herein. Health Benefits segment operating revenue was $42.7 billion in the second quarter of 2026, an increase of $1.1 billion, or 3 percent compared to the prior year quarter, driven primarily by higher premium yields, partially offset by expected declines in our Medicare Advantage, Medicaid, and Employer Group risk membership. Operating gain was $0.9 billion, a decrease year over year, reflecting higher benefit expense and targeted investments to support our workforce and strengthen enterprise performance, partially offset by operating revenue growth. Medical membership of approxim